MYTESI DIRECT
Dead / Cancelled — Cancelled — Section 8 (as of 02 May 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87814257
- Registration number
- 5584837
- Mark type
- Stylized text
- Filed
- 28 Feb 2018
- Published for opposition
- 31 Jul 2018
- Registered
- 16 Oct 2018
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 035 — Advertising and business services: Business administration of pharmacy reimbursement programs and services; Mail order pharmacy services; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Specialized retail pharmacy services for patients with particular medical conditions
Owner
- Napo Pharmaceuticals, San Francisco, CA, US
- Napo Pharmaceuticals, San Francisco, CA, US
- Napo Pharmaceuticals, San Francisco, CA, US
Prosecution history
- 02 May 2025 — CANCELLED SEC. 8 (6-YR)
- 16 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jul 2018 — PUBLISHED FOR OPPOSITION
- 11 Jul 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jun 2018 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 25 Jun 2018 — ASSIGNED TO LIE
- 14 Jun 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jun 2018 — EXAMINER'S AMENDMENT ENTERED
- 14 Jun 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jun 2018 — EXAMINERS AMENDMENT E-MAILED